Tag: alexion pharmaceuticals
May 28, 2019
8 Small Biotech ETFs
Want to invest in small biotech ETFs? Here we profile eight that life science investors may want to look into.
March 26, 2019
7 Potential Blockbuster Drugs Investors Should Watch for in 2019
A report by Cortellis says that seven drugs entering the market in 2019 are projected to reach blockbuster status by... September 24, 2018
Alexion Announces Successful Phase 3 PREVENT Study of Soliris (Eculizumab) in Patients with Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals (NASDAQ:ALXN) today announced positive topline results from the Phase 3 PREVENT study of Soliris (eculizumab) in patients with anti-aquaporin-4 (AQP4)... June 28, 2018
Alexion Submits Application for Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria in the EU
Alexion Pharmaceuticals (NASDAQ:ALXN) announced the submission of a Marketing Authorization Application to the European Medicines Agency (EMA) for ALXN1210, the...
February 26, 2018
Positive Regulatory News from Two Pharmaceutical Companies Triggers Share Price Increases
Investors and analysts are focusing on KemPharm and Achillion after both companies received recent positive regulatory news. April 25, 2017
biOasis Technologies Appoints New CEO
biOasis Technologies announced the appointment of Dr. Mark Day as president and CEO of the company.
March 19, 2017